Business
Ipsen - Half year statement - 2026 06 30
Ipsen - Half year statement - 2026 06
About this update from Ipsen Sa
Half-year statement of the liquidity agreement between IPSEN SA and NATIXIS ODDO BHFPARIS, 07 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that under the liquidity agreement entrusted by IPSEN S.A. to NATIXIS ODDO BHF, as of June 30, 2026, the following resources were included to the dedicated liquidity account:3,495 shares €6,028,648.09 It is reminded that as of the date of the signature of the agreement, the following assets were allocated to the liquidity account:12,751 shares€3,137,934.80 Between January 1st, 2026 and June 30, 2026 have been executed:3,548 purchase transactions 3,803 sell transactions Under the same period, the volume traded represented:646,724 shares and €100,273,554.20 to the purchase 673,293 shares and €104,175,765.30 to the sellAbout Ipsen We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Our pipeline is fueled by internal and external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries and our partnerships around the world enable us to bring medicines to patients in more than 100 countries. Ipsen is listed in Paris (Euronext: IPN) and in the U.S. through a Sponsored Level I American Depositary Receipt program (ADR: IPSEY). For more information, visit ipsen.com.Ipsen Contacts Investors Henry [email protected]+33 7 66 47 11 49Khalid [email protected] +33 6 66 01 95 26 Media Sally [email protected]+1 857 320 0517Anne [email protected]+33 7 67 34 72 96Disclaimers and/or forward-looking statements The forward-looking statements, objectives and targets contained herein are based on Ipsen’s management strategy, current views and assumptions. Such statements involve known and unknown risks and uncertainties that may cause actual results, performance or events to differ materially from those anticipated herein. All of the above risks could affect Ipsen’s future ability to achieve its financial targets, which were set assuming reasonable macroeconomic conditions based on the information available today. Use of the words ‘believes’, ‘anticipates’ and ‘e...